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Abstract
Recent advances in genomic technologies now enable a reunion of molecular
and evolutionary biology. Researchers investigating naturally living animal pop-
ulations are thus increasingly able to capitalize upon genomic technologies to
connect molecular findings with multiple levels of biological organization.
Using this vertical approach in the laboratory, epigenetic gene regulation has
emerged as an important mechanism integrating genotype and phenotype. To
connect phenotype to population fitness, however, this same vertical approach
must now be applied to naturally living populations. A major obstacle to study-
ing epigenetics in noninvasive samples is tissue specificity of epigenetic marks.
Here, using the mouse as a proof-of-principle model, we present the first
known attempt to validate an epigenetic assay for use in noninvasive samples.
Specifically, we compare DNA methylation of the NGFI-A (nerve growth fac-
tor-inducible protein A) binding site in the promoter of the glucocorticoid
receptor (Nr3c1) gene between central (hippocampal) and peripheral noninva-
sive (fecal) tissues in juvenile Balb/c mice that had received varying levels of
postnatal maternal care. Our results indicate that while hippocampal DNA
methylation profiles correspond to maternal behavior, fecal DNA methylation
levels do not. Moreover, concordance in methylation levels between these
tissues within individuals only emerges after accounting for the effects of
postnatal maternal care. Thus, although these findings may be specific to the
Nr3c1 gene, we urge caution when interpreting DNA methylation patterns from
noninvasive tissues, and offer suggestions for further research in this field.
Introduction
With the advent of genomic resources, reuniting molecu-
lar and evolutionary biology has become the subject of
intensive research investigation (Dean and Thornton
2007). Such efforts have led to a deeper understanding of
the relationship between genotype, phenotype, and fitness
(Bradley and Lawler 2011). This vertical and integrative
approach is especially useful for assessing natural popula-
tions, in which the use of whole-organism performance
(made up of physiological, morphological, and behavioral
phenotypes) can be used to determine fitness.
Understanding the evolutionary trajectory of a species
requires an understanding of both its genetic makeup and
its ecology (behavior and environment). Although this
model was implicated in the modern synthesis, only
recently has the technology been available to concurrently
examine multiple levels of biological organization (Dalziel
et al. 2009). Indeed, a rapidly expanding body of theoreti-
cal and empirical literature spanning multiple disciplines
has recently emerged (Ellegren and Sheldon 2008;
Piertney and Webster 2010; Bradley and Lawler 2011;
Martin et al. 2011).
One incipient theme in this “revolution” is the role of
epigenetics in mediating the relationship between
genotype and phenotype. Epigenetics is the study of
mitotically (and potentially meiotically) heritable molecu-
lar modifications to DNA and chromatin that do not
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involve alteration to the underlying DNA sequence (Reik
et al. 2001; Li 2002). These molecular modifications can
lead to long-term variations in gene expression through
stable gene silencing/activation. Increasingly, it is recog-
nized that epigenetic marks provide a mechanistic link
between environmental experiences, such as stress, social
interactions, nutrition, and toxicological exposures, and
variation in a broad range of phenotypic outcomes,
including disease risk (Jirtle and Skinner 2007; Cham-
pagne 2010; Verhoeven et al. 2010). Although the DNA
sequence is stable and highly conserved within and across
generations, epigenetic modifications have the potential to
be dynamic throughout life and can be heavily influenced
by external factors (Reik et al. 2001). Thus, external
effects on the epigenome may alter patterns of gene
expression, potentially giving rise to phenotypic diversity.
Epigenetic modifications include chromatin remodeling,
post-translational histone tail modifications, DNA methyl-
ation, and more recently have expanded to include
noncoding RNA and microRNA gene regulation (Jab-
lonka and Lamb 2005; Matzke and Birchler 2005;
Milosavljevic 2011).
Although epigenetic effects have been proposed to be
important for evolutionary processes (Jablonka and Lamb
2005; Feinberg and Irizarry 2010; Verhoeven et al. 2010;
Danchin et al. 2011), empirical data supporting the trans-
generational inheritance and fitness consequences of
epigenetic marks are still quite limited. Studies of natu-
rally living populations are crucial to the empirical testing
of epigenetic theories (Bossdorf et al. 2008; Ledón-Rettig
et al. in press). The acquisition and analysis of DNA from
naturally living populations can be problematic, however,
as noninvasive techniques must often be used. In recent
years, the collection of fecal samples and extraction of
genomic DNA has been validated across a wide variety of
taxa, and has been critical in the advancement of molecu-
lar ecology (Beja-Pereira et al. 2009; Perry et al. 2010).
In principal, these methods may also be used to obtain
the molecular samples necessary for DNA methylation
analyses.
The use of bio-available tissues for epigenetic analyses
faces a unique problem because epigenetic marks can be
cell specific and are thought to maintain tissue-specific
patterns of gene expression among differentiated cell
types. For example, tissue-specific differentially methylat-
ed regions (T-DMRs) occur both within (De Bustos et al.
2009) and outside of (Eckhardt et al. 2006) CpG islands.
For molecular ecologists, this specificity poses one of the
largest obstacles to using non-invasive samples for epige-
netic analysis. That is, there is no a priori reason to
expect that peripheral samples (i.e., from feces, saliva, or
other available tissues) will contain biologically relevant
DNA methylation data and there may be concordance
between tissues for some loci (Waterland and Jirtle 2003),
but not others. Thus, it is necessary to validate candidate
genes from peripheral samples to ensure that they predict
biologically relevant methylation data in key target tissues
(e.g., brain, liver, spleen).
As the first known attempt to explicitly investigate the
epigenetic relationship between target tissue and
bio-available samples for use in evolutionary research, this
study compared DNA methylation levels of the NGFI-A
(nerve growth factor-inducible protein A) binding site of
the glucocorticoid receptor gene (Nr3c1) across hippo-
campal and fecal samples in the mouse (Mus musculus).
This locus was chosen because it is highly conserved
across mammals (Turner and Muller 2005). Additionally,
methylation at this locus has been previously shown to
vary across individuals as a function of the experience of
variation in postnatal (PN) maternal environment (Wea-
ver et al. 2004). The goals of this study were to (1) deter-
mine the concordance in CpG methylation patterns of the
Nr3c1 gene in hippocampal and fecal samples, (2) identify
CpG sites within this genomic location where DNA meth-
ylation differed across individuals as a function of PN
experience, and (3) to assess whether this differential
methylation was detectable in both hippocampal and fecal
samples.
Methods and Materials
Animals and assessment of maternal
behavior
All subjects were Balb/c laboratory mice (M. musculus)
purchased from Jackson Laboratories, and all procedures
were undertaken in accordance with guidelines of the
NIH regarding the Guide for the Care and Use of Labora-
tory Animals and with the approval of the Institutional
Animal Care and Use Committee (IACUC) at Columbia
University. Animals were housed at Columbia University
on a reverse 12-h-dark and 12-h-light cycle, under a
constant temperature of 21°C and 55% humidity. All
animals were provided ad libitum access to water and
chow diet. Behavioral observations took place during the
dark period of the light cycle, this being the period when
mice are most active.
Following a 2-week habituation period, group-housed
(2–3/cage) female mice were mated for 14–16 days.
Females were singly housed at approximately gestational
day 18 and then monitored daily to determine the timing
of birth of the litter. On the day of birth at PN day 0,
pups were weighed and counted and then dams and litters
were left undisturbed throughout the maternal observation
period. As litter size was not standardized, we used litter
size/weight as a covariate in the statistical analyses.
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The procedure for assessing variation in maternal
behavior has been previously described (Champagne et al.
2007). Briefly, maternal behavior of all dams (n = 14)
was scored from day 1 through day 6 postpartum, and
the observers were trained to a high level of inter-rater
reliability (i.e., >0.90). Four observations were conducted
daily, with two within 4 h of the onset of the dark cycle,
and two near the end of this period. Within each obser-
vation period, the behavior of each dam was scored every
3 min (20 observations/period 9 4 periods per day = 80
observations/mother/day = 480 observations per dam
over the 6 days). The following behaviors were scored:
mother licking and grooming any pup, mother in nursing
posture over pups, nest-building, self-grooming, eating,
and drinking. The calculated percent frequency of nursing
and pup licking/grooming was used in subsequent
analyses. This percentage represents the total times the
behavior was observed divided by the total number of
observations conducted. Both overall maternal care
(PN1-6) and maternal care occurring on PN1 were
included as predictors of offspring outcomes. Due to the
overall low levels of pup licking/grooming in this
sample (M = 3.83%, SD = 1.93%), nursing frequency
(M = 31.06%, SD = 2.03%), which ranged from 11.67%
to 49.58% in this sample, was used as the primary
measure of maternal care (although pup licking/grooming
was used as a statistical covariate).
Pups were weaned at PN day 28 and housed in same-
sex groups of 3–4/mice per cage. A total of 22 (n = 22)
pups were included in the initial analysis (n = 12 female;
n = 10 male). Pups were derived from a total of 14 litters
with only four litters sampled more than once (2–4
pups).
Tissue collection
At PN day 35, mice were singly housed for 12 h and
subsequently sacrificed. Whole-brain and fecal boli sam-
ples were collected (Columbia University), snap frozen on
dry ice, and stored in a 80°C freezer prior to shipment
to the University of Michigan (UM). Upon receipt at
UM, brain and fecal samples were stored at 80°C until
the time of dissection or DNA extraction.
Brain dissection
All brains underwent gross dissection for a hippocampi-
enriched block of tissue. This was achieved using a mouse
brain slicer matrix (Zivic Instruments, Pittsburgh, PA).
Brains were brought to 20°C and stored in a microtome
chamber until the moment of dissection. The brain slicer
was chilled to 80°C on dry ice and was removed from
dry ice for each dissection. Each brain was placed in the
matrix, in a dorsal–ventral orientation. Four-millimeter
slices were created using razor blades inserted into the
matrix. Slices were removed and placed back onto dry
ice. Slices containing the dorsal hippocampus were visu-
ally identified by comparisons to a mouse brain atlas
(Paxinos and Franklin 2004). This slice (coronal plane)
was further dissected with just a razor blade to remove
nonhippocampal tissues dorsally, ventrally, and laterally.
This hippocampal-enriched area was then bisected along
the midline and tissue halves placed in separate aliquots.
Additional aliquots of forebrain, hindbrain, and extra-
hippocampal regions from the original slice were all
placed in 1.5-mL conical microcentrifuge tubes and
returned to 80°C for storage.
DNA extraction
One aliquot of hippocampal tissue was removed from
80°C and thawed to room temperature. DNA was
extracted using the Qiagen DNeasy kit (Valencia, CA),
according to the manufacturer’s manual spin-column
protocol. Samples were eluted into 200 lL of TE buffer.
Two fecal pellets were thawed to room temperature, and
DNA was extracted using the Maxwell-16 Instrument
(Promega Corporation, Madison, WI). Fecal DNA
samples were eluted into 350 lL of TE buffer.
Pyrosequencing of bisulfite-treated tissue
samples
Bisulfite pyrosequencing (Tost and Gut 2007) was used to
obtain methylation values for two CpG sites within the
NGFI-A binding region of Nr3c1 (Fig. 1). Samples were
bisulfite converted using the Qiagen Epitect kit. Conver-
sions were executed according to the manufacturer’s auto-
mated protocol for the Qiagen Qiacube. Samples were
then amplified using the following primers: (5′ FBIO-GAT
TTG GTT TGG GAG GGA AAG 3′) and (5′ R-CCT CTA
CTA AAA TAA CAC ACT TC 3′), and Qiagen HotStarTaq
master mix with an annealing temperature of 55°C. Poly-
merase chain reaction (PCR) products were resolved by
gel electrophoresis prior to pyrosequencing. This step
revealed three fecal samples that failed to amplify, result-
ing in a reduced sample size for fecal methylation analysis
(hippocampus, n = 22; fecal, n = 19). To ensure that tis-
sue-specific differences in CpG methylation were not the
consequence of this disparity in sample size, all analyses
comparing effects in hippocampal versus fecal samples
were restricted to individuals in which both tissues were
available (n = 19). PyroGold reagents (Qiagen) were used
to prepare samples for pyrosequencing according to the
manufacturer’s instructions. CpG methylation was quanti-
fied using the Pyromark MD system and Pyro Q-CpGt
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1.0.9 software (Qiagen). All samples (hippocampal and
fecal) were processed on three separate runs, however,
only the third contained duplicates. Only samples from
the third run were used to test duplicate reliability. The
Pyromark MD software has a number of built-in quality
controls, meaning that every sample either “passes,”
“fails,” or “conditionally passes.” Methylation values were
only taken from samples that “passed” at both CpG sites.
Statistics
All data analysis was conducted with SPSS (version 19.0
for PC), and the statistical threshold for all tests was set
to P <0.05. Duplicate reliability (a quality control mea-
sure) was assessed using a paired T-test to compare meth-
ylation values of only the samples where both duplicates
“passed” (n = 20 sets of n = 41 total sets). DNA methyla-
tion percentages were subsequently averaged within indi-
viduals across duplicates and runs for each CpG site and
tissue. One-way repeated measures analysis of variance
(ANOVA) was used to determine the potential impact of
sex and tissue type on average Nr3c1 DNA methylation.
T-tests were used to determine differences in methylation
across individual CpG sites within each tissue (i.e., aver-
age% methylation at site 1 versus 2 in hippocampal/fecal
tissue). Pearson correlation coefficients were used to
determine the association between CpG methylation at
CpG sites 1 and 2 and between percent DNA methylation
in brain and fecal samples (i.e., degree of correlation in
% methylation at sites 1 and 2 in hippocampal/fecal
tissue; correlation between brain and fecal CpG methyla-
tion levels at site 1, site 2, and the average of sites 1 and
2). A multiple weighted least squares regression model
was used to examine the relationship between maternal
and life history variables (nursing, pup licking, litter size,
and litter weight) and DNA methylation levels at each of
the two CpG sites measured across both tissues (hippo-
campus and fecal boli). The association between methyla-
tion levels in fecal boli and those in the hippocampus was
analyzed using multiple weighted least squares regression
models that were run in a stepwise fashion. First, methyl-
ation in the boli alone was used to predict hippocampal
methylation followed by a second model that included
maternal care variables (nursing, licking). The change in
variance explained in the subsequent model (R2-change)
was tested using an F-test.
Results
Duplicates
Comparison of CpG methylation levels obtained in the
duplicates of the assay was conducted to determine the
stability of the assay and the consistency of the percent
methylation levels. At CpG site 1, there was no significant
difference in methylation between the first duplicate
(M = 5.11%, SD = 2.38) and the second duplicate
(M = 4.62%, SD = 1.68; t(20) = 0.92, P = 0.37; Fig. 2A).
Similarly, there was no significant difference at CpG site 2
between the first duplicate (M = 14.40%, SD = 3.71) and
the second duplicate (M = 13.79%, SD = 3.49;
t(20) = 1.01, P = 0.32; Fig. 2B). As duplicates did not
show any difference, the methylation values across dupli-
cates and across all three runs were averaged to obtain site
and tissue-specific methylation values for each sample.
Overall CpG methylation
Average percent CpG methylation was not found to vary
as a function of sex (F(1, 18) = 0.06, n.s.) or tissue type
(F(1, 18) = 0.43, n.s.) (Table 1). In both brain
(t(18) = 21.07, P < 0.001) and fecal boli samples
(t(18) = 8.79, P < 0.001), average % DNA methylation was
found to be elevated at CpG site 2 compared with CpG








Figure 1. (A) Genomic organization (not to scale) of the mouse Nr3c1 gene, showing the location of the NGFI-A binding site (arrow) targeted by
pyrosequencing primers (B). Architecture of Nr3c1 NGFI-A binding site. The location of the forward and reverse primers is indicated by arrows
and gray highlighting, and the sequencing primer is identified by dark gray. The forward primer was biotinylated, as shown by the dot at the end
of the arrow. The NGFI-A binding site is indicated in the box (dashed line). Sites referred to as CpG 1 and CpG 2 are indicated.
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site 1. In brain tissue, there was a highly significant corre-
lation between CpG methylation levels at site 1 and 2
(r(19) = 0.93, P < 0.001). However, in fecal boli, this con-
cordance in CpG methylation at sites 1 and 2 was not sig-
nificant (r(19) = 0.29, n.s.).
Maternal care and CpG methylation
Frequency of nursing and pup licking at PN1 and across
the first week postpartum were found to be significantly
correlated (PN1: r(22) = 0.50, P < 0.05; PN1-6:
r(22) = 0.77, P < 0.001). Although overall nursing (PN1–
PN6) was not a significant predictor of Nr3c1 methylation
levels, nursing frequency on PN day (PN1) was negatively
associated with juvenile hippocampal Nr3c1 methylation
levels of CpG site 1 (t(18) = 3.61, P < 0.01; Fig. 3A) and
at CpG site 2 (t(18) = 4.75, P < 0.001; Fig. 3B) after
accounting for pup licking, litter size, and litter weight.
This effect of maternal nursing on Nr3c1 methylation
appears to be tissue specific, as there was no significant
relationship between PN maternal nursing and levels of
Nr3c1 methylation in the fecal boli at either of the CpG
sites measured (fecal CpG site 1: t(18) = 0.09, n.s.; fecal
CpG site 2: t(18) = 0.80, n.s.; Fig. 3C and D).
Predicting hippocampal methylation levels
using fecal boli methylation
Average Nr3c1 methylation levels in fecal boli was
found to be a poor predictor of Nr3c1 methylation levels
in the hippocampus (t(18) = 1.60, n.s.) and the within-
individual correlation in percent methylation between
these tissues was found to be nonsignificant (see Fig. 4).
However, a significant relationship between the average
methylation levels within brain and fecal boli (averaged
across CpG sites 1 and 2) was found to emerge after
controlling for the maternal nursing and licking received
during the first PN day (t(18) = 2.21, P < 0.05). Thus,
CpG methylation levels in boli predicted those in the
brain only after accounting for PN maternal care, vari-
ables which contributed significantly to the overall model
(R2-change = 0.43, F(2, 15) = 7.49, P < 0.01). In other
words, methylation levels in fecal boli were only a good
predictor of those in the brain after holding early-life
experiential variables constant. This was also marginally
true for the relationship between specific CpG sites in the
boli and their corresponding CpG sites in the brain.



























































Figure 2. Comparison of pyrosequencing run #3 duplicates for (A)
CpG position 1 and (B) CpG position 2.
Table 1. Percent DNA methylation within the Nr3c1 promoter
(mean ± SEM).
Tissue Sex CpG site 1 CpG site 2
Brain Male 5.07 (0.27) 13.80 (0.73)
Female 5.16 (0.37) 13.41 (0.94)
Fecal boli Male 5.33 (0.46) 14.58 (0.65)
Female 6.25 (1.58) 13.21 (0.61)
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Figure 3. Correlation between postnatal nursing on PN1 and CpG
methylation in brain and fecal boli samples. Note that indicated P-
values reflect the significance of the regression model adjusting for
the effects of pup licking, litter size, and litter weight.
ª 2012 The Authors. Published by Blackwell Publishing Ltd. 3127
S. A. Liberman et al. Nr3c1 Methylation Across Tissues in the Mouse
failed to predict methylation at the corresponding site in
the hippocampus (CpG site 1: t(18) = 1.35, P = n.s; CpG
site 2: t(18) = 1.90, P = 0.08), subsequent analyses
revealed that specific CpG sites in the boli became
marginally good predictors of methylation at their
corresponding CpG sites in the hippocampus (CpG site 1:
t(18) = 1.84, P = 0.09; CpG site 2: t(18) = 1.86,
P = 0.08) only after accounting for PN nursing and lick-
ing (CpG site 1: R2-change = 0.31, F(2, 15) = 3.84,
P < 0.05; CpG site 2: R2-change = 0.40, F(2, 15) = 7.03,
P < 0.01).
Discussion
This study is the first known attempt to explicitly validate
the use of fecal samples for ecological methylation analy-
ses. The results indicate that an element of the social
environment, maternal behavior exhibits an effect on
brain DNA methylation. These findings are supported by
previous work showing maternally mediated methylation
differences in the NGFI-A binding region of Nr3c1 in the
rat (Weaver et al. 2004). Novel to this study, however, we
have shown that this socially mediated methylation pat-
tern is specific to the brain, and is not detected in fecal
DNA. Moreover, Nr3c1 CpG methylation within individu-
als was not found to be correlated between brain and
fecal DNA unless the effects of PN maternal care were
accounted. As such, the tissue-specific effects of maternal
care may account for the lack of concordance between
DNA methylation levels between central (hippocampal)
and peripheral (fecal) tissue. As maternal care increases
Nr3c1 methylation in the hippocampus, but not in fecal
samples, this tissue-specific effect appears to induce
increased within-individual divergence in Nr3c1 methyla-
tion. Although the Nr3c1 gene is highly conserved across
vertebrates (Thornton 2001), it is not present in bacteria.
Therefore, it is unlikely that the locus-specific primers
spuriously amplified non-target DNA. Additionally, the
fecal samples amplified successfully with the primers spe-
cific to the murine NGFI-A locus, indicating sufficiently
high DNA quality, even after bisulfite conversion. Thus,
the CpG methylation characteristics in fecal samples can-
not be attributed to low DNA quality.
These results highlight the importance of validating
functional epigenetic results in bioavailable tissues.
Although epigenetic studies analyzing DNA methylation
in peripheral tissues from wild populations have only
just begun to emerge (Schrey et al. 2012), numerous epi-
demiological studies have been conducted using blood as
a surrogate biomarker. Blood is a relatively noninvasive
sample tissue that yields high-quality DNA, but is not
necessarily considered a primary or central tissue. As
such, results that indicate methylation effects in blood
(Oberlander et al. 2008; Kinnally et al. 2011) must be
interpreted cautiously if their functional effects are pos-
tulated to take place in the brain. Therefore, with our
results in mind, it will be important to conduct proof-
of-principle studies validating functional epigenetic
results with noninvasive samples. Moreover, our results
indicate that environmental exposures may increase the
discordance in DNA methylation levels between different
tissues – a phenomenon that merits further investiga-
tion.
Despite this finding of a lack of concordance between
central and peripheral DNA methylation patterns at one
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Figure 4. Correlation between Nr3c1 CpG methylation in fecal boli
and hippocampal samples. (A) Average% methylation across sites 1
and 2 (r = 0.36, n.s.), (B) site 1 (r = 0.31, n.s.), and (C) site 2
(r = 0.42, P = 0.08) correlations.
3128 ª 2012 The Authors. Published by Blackwell Publishing Ltd.
Nr3c1 Methylation Across Tissues in the Mouse S. A. Liberman et al.
epigenetically labile locus, it is still extremely important
for molecular ecologists to obtain DNA methylation
information from naturally living populations. Rather, we
encourage an increased research effort toward the com-
parison of methylation patterns across tissues. Specifically,
comparisons with multiple relevant peripheral tissues
such as saliva and feces as well as increased sample sizes
to assess tissue concordance will be fruitful for molecular
ecologists, behavioral biologists, and psychologists. In
addition to these kinds of validation studies, alternative
methods and nonfunctional loci remain an alternative
option to studying epigenetic patterns in wild popula-
tions. In mice (Weinhouse et al. 2011) and humans
(Waterland et al. 2010), a burgeoning literature is identi-
fying metastable epialleles (MEs). These loci represent
regions where stable methylation patterns are established
in early embryonic development, resulting in concordant
methylation patterns across all germ layers. Despite being
similar across tissues, MEs vary across individuals. As
such, they act as biosensors for individual differences in
DNA methylation, and are detected across tissue from the
three germ layers (Waterland and Jirtle 2003; Dolinoy
et al. 2006). In some ways, MEs are ideal for studying
natural populations, but there are drawbacks. MEs require
extensive validation (Weinhouse et al. 2011), and may
not regulate a genomic region of functional interest.
Another option available to molecular ecologists is the
LUminometric Methylation Assay (LUMA; Karimi et al.
2006). This methylation-dependent restriction enzyme-
based assay provides a measure of methylation at CCGG
sites throughout the entire genome regardless of location,
representing the degree to which the genome is globally
methylated. This assay incorporates combined DNA cleav-
age by methylation sensitive restriction enzymes, similar
to the methylation-sensitive amplified fragment-length
polymorphism (MS-AFLP) approach, but quantifies the
resulting methylation values by polymerase extension
assay on a MD 96 PyrosequencingTM platform. In this
way, experiments can be scaled up and automated. Addi-
tional benefits of the LUMA assay include: (1) minimal
starting DNA as bisulfite conversion is not necessary, (2)
time and cost savings compared with other methylation
assays, and (3) the ability to measure methylation in spe-
cies without a reference sequence, where sequencing-based
methylation assays cannot (Head et al. 2012). This
approach can be useful for detecting large-scale stimuli
(such as environmental toxicants), and may therefore
have high utility for conservation efforts. However, this
method yields no functional information; it is not possi-
ble to test hypotheses about specific genes or biological
pathways. Additionally, the LUMA-based approach must
be applied to tissues that contain only target-species
DNA. Fecal samples cannot be used because they contain
DNA from bacteria and plants, often in much higher
quantity than the target-species DNA.
Conclusion
This study presents a novel tissue-specific comparison of
methylation between brain and feces, specifically designed
for molecular ecologists working with noninvasive sam-
ples. We found that fecal DNA methylation profiles at the
NGFI-A binding site of Nr3c1 were not correlated with
DNA methylation profiles in hippocampal tissue and were
not significantly influenced by postpartum maternal
behavior, suggesting that molecular ecologists should
exercise caution when applying epigenetic methods to
noninvasive samples. Tissue specificity is a pervasive sig-
nature of the epigenome, and must be accounted for
when analyzing peripheral tissues. Conversely, these
results are specific to only two CpG sites in the mouse
genome within two tissue types, and may not be general-
izable to other loci, other tissues, or other species. In
addition, epigenetic effects may vary dependent on the
type of environmental exposure, and thus the effects we
observe in response to maternal care may not generalize
to other types of experiences/exposures. Further studies
will be needed to identify the functional regions that can
be detected in noninvasive samples. Where explicit com-
parisons of central and peripheral tissues are not possible,
other methods can be utilized. Assaying MEs, or use of
global methylation approaches such as the LUMA assay,
may be fruitful avenues for further molecular ecology
research.
Acknowledgments
This study was supported by Grant Number DP2O
D001674 from the Office of the Director, National Insti-
tutes of Health (F. A. C.) as well as the University of
Michigan NIEHS P30 Core Center ES017885 (D. C. D.).
The authors have no conflicts of interest and declare no
competing financial interests.
Author’s Contributions
S. A. L. with input from F. A. C. and D. C. D. conceived of
the study question and designed the study protocols. F. A. C.
and R. M. oversaw behavioral assays and collected mouse
brain and fecal tissue. S. A. L. and R. T. performed
hippocampal extractions. S. A. L. with input from D. C. D.
conducted DNA extraction, assay design, and quantitative
methylation assays. F. A. C., R. M., and S. A. L. performed
statistical analysis, with input from all authors. S. A. L.
drafted the manuscript, and all authors edited and approved
the final draft of the manuscript.
ª 2012 The Authors. Published by Blackwell Publishing Ltd. 3129




Beja-Pereira, A., R. Oliveira, P. C. Alves, M. K. Schwartz,
G. Luikart, and USDA FS. 2009. Advancing ecological
understandings through technological transformations in
noninvasive genetics. Mol. Ecol. Resour. 9:1279–1301.
Bossdorf, O., C. L. Richards, and M. Pigliucci. 2008.
Epigenetics for ecologists. Ecol. Lett. 11:106–115.
Bradley, B. J., and R. R. Lawler. 2011. Linking genotypes,
phenotypes, and fitness in wild primate populations. Evol.
Anthropol. 20:104–119.
Champagne, F. A. 2010. Epigenetic influence of social
experiences across the lifespan. Dev. Psychobiol. 52:299–311.
Champagne, F. A., J. P. Curley, E. B. Keverne, and P. P. Bateson.
2007. Natural variations in postpartum maternal care in
inbred and outbred mice. Physiol. Behav. 91:325–334.
Dalziel, A. C., S. M. Rogers, and P. M. Schulte. 2009. Linking
genotypes to phenotypes and fitness: how mechanistic
biology can inform molecular ecology. Mol. Ecol.
18:4997–5017.
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